Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Xennex has announced that the Japan Patent Office has licensed GeneCards. Xennex has also announced that it has selected Bioscene Informatics as its exclusive partner for the distribution of GeneCards in Japan.
Subscribe to our email newsletter
GeneCards will be utilized to assist the Japan Patent Office (JPO) in the review and approval of patent applications in the life sciences area. With this agreement, GeneCards becomes an important component in the process of approving relevant biotech patent applications at the JPO. Patent examiners from the JPO will access GeneCards to conduct prior art research and help determine if an invention can be patented.
GeneCards is widely used in Japan, by academic researchers and by several of the world’s top companies based in Japan. Bioscene will work closely with Xennex to expand the Japanese market for GeneCards in the R&D and intellectual property fields.
GeneCards is an integrated database of human genes that includes automatically mined genomic, proteomic, and transcriptomic information, with major focus on functional genomics and medical aspects including involvement in diseases. GeneCards offers concise information about the structure and function of human genes.